|
Tesetaxel Results as Initial Chemotherapy for Women With Recurrent Breast Cancer to be Highlighted at ASCO
--Promising results for response and progression-free survival
finance.yahoo.com
Hybrid vaccine demonstrates potential to prevent breast cancer recurrence
( University of Texas M. D. Anderson Cancer Center ) A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at the University of Texas MD Anderson Cancer Center.
www.eurekalert.org
Breast cancer vaccine that elicits powerful immune response also improves recurrence rates
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
www.news-medical.net
IBN Discovers Human Neural Stem Cells with Tumor Targeting Ability - A Promising Discovery for Breast Cancer Therapy
Singapore, Apr 20, 2012 - (ACN Newswire) - Could engineered human stem cells hold the key to cancer survival?
www.japancorp.net
North American Seminars, Inc, Introduces Advanced Management of Breast Cancer Rehabilitation, a Physical Therapy and ...
North American Seminars introduces a two day live continuing education course for Occupational Therapists and Physical Therapists, Advanced Management of Breast Cancer Rehabilitation. This Live International CME course is designed to expand and advance current clinical knowledge by providing more in depth clinical information needed to problem solve through a complex variety of breast cancer ...
news.yahoo.com
3D Biomatrix™ Awarded a Phase I STTR Award to Develop 3D Metastatic Prostate Cancer Assay
3D Biomatrix, which develops and sells tools that mimic the human cellular environment for drug discovery research and testing, has been awarded a Phase I STTR grant from the National Institutes of Health (NIH) for further development of its Perfecta3D[TM] Hanging Drop Plates to develop a three-dimensional (3D) cell assay for metastatic prostate cancer. ...
news.yahoo.com
RANK protein promotes the initiation, progression and metastasis of human breast cancer
( IDIBELL-Bellvitge Biomedical Research Institute ) Researchers from the Bellvitge Biomedical Research Institute have shown that over-activation of the RANK signaling pathway promotes the initiation, progression and metastasis of tumors in human breast epithelial cells by de-differentiation of breast cells to stem cells. The results of this study have been advanced in the electronic edition of ...
www.eurekalert.org
'Fertilizing' bone marrow helps answer why some cancers spread to bones
( University of Michigan ) Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.
www.eurekalert.org
Reminder: Exelixis Announces Data Presentations, Webcast of Investor Briefing in Conjunction With 2012 ASCO Annual ...
Exelixis, Inc. reiterated its slate of activities in conjunction with the 2012 American Society of Clinical Oncology Annual Meeting, which will be held June 1-5, 2012, in Chicago, Illinois.
finance.yahoo.com
‘Fertilizing’ Bone Marrow Helps Explain Why Some Cancer Spreads To Bones
Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.
detroit.cbslocal.com
|
